Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer using multi-specific binding proteins that bind NKG2D, CD16 and a tumor-associated antigen

Methods of treating cancer using multi-specific binding proteins that bind NKG2D, CD16 and a tumor-associated antigen

US Patent 12377144 · Granted Aug 5, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CTLA-4 antibodies and methods of use thereof2025
Proteins binding NKG2D, CD16 and CLEC12A2024
Antibodies and methods of use thereof2024
Heterodimeric Fc-fused proteins2023
Anti-CTLA-4 antibodies and methods of use thereof2023
Anti-CTLA-4 antibodies and methods of use thereof2021
Anti-CTLA-4 antibodies and methods of use thereof2021
PD-1/PD-L1 inhibitors for the treatment of cancer2020
Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof2017
Protective seal for cans2002
Protective seal for cans2002